Stroke patients |
14 |
45 |
37 |
Non stroke |
17 |
55 |
63 |
|
Studies of stroke patients |
|
% of studies of stroke patients |
% of stroke patients |
|
Recorded stroke sub-type |
13 |
87 |
88 |
Inpatients and outpatients |
1 |
7 |
1.2 |
Inpatients only |
12 |
80 |
96 |
USA |
3 |
20 |
22 |
Europe |
5 |
33 |
48 |
Asia |
7 |
47 |
29 |
|
Studies of subtyped stroke patients |
|
% of studies that subtyped stroke |
% of patients with subtyped stroke |
|
OCSP |
1 |
8 |
7 |
TOAST |
12 |
92 |
93 |
CT Imaging |
4 |
31 |
40 |
MRI |
2 |
15 |
12 |
CT and MRI |
4 |
31 |
17 |
Measured proteinuria |
4 |
31 |
9 |
Measured eGFR |
9 |
69 |
69 |
Patients that developed acute kidney injury |
1 |
8 |
26 |
|
Studies of imaging features of SVD patients |
|
% of studies of imaging features of SVD |
% of subjects in the studies of imaging features of SVD |
|
Healthy volunteers |
8 |
47 |
57 |
Diabetic patients |
4 |
24 |
10 |
Any vascular risk factor |
2 |
12 |
4 |
Hypertensive patients |
1 |
6 |
0.2 |
Hypertensive patients and their siblings |
1 |
6 |
11 |
Excluded previous stroke |
10 |
59 |
84 |
Excluded severe renal impairment |
9 |
53 |
35 |
1.5T |
14 |
82 |
86 |
0.5T |
3 |
18 |
14 |
Fazekas or similar |
5 |
29 |
24 |
Count of silent brain infarcts |
6 |
35 |
52 |
Automated measure of the volume of WMH |
5 |
29 |
24 |
Images analysed by a blinded observer |
9 |
53 |
46 |
Measured eGFR |
8 |
47 |
70 |
Measured proteinuria |
5 |
29 |
13 |
Measured both |
3 |
18 |
14 |
Measured serum creatinine |
1 |
6 |
2 |
Multivariate analysis |
13 |
76 |
81 |